PMI06

Precision Molecular

Drug Candidate

PMI06

Summary

Potential best-in-class PD-L1 imaging agent for immuno-oncology

Mechanism of Action

PET ligand targeting PD-L1

Indication

Immuno-oncology

Development Stage

Phase I